Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea

BACKGROUND: As targeted therapy becomes increasingly important, diagnostic techniques for identifying targeted biomarkers have also become an emerging issue. The study aims to evaluate the cost-effectiveness of treating patients as guided by epidermal growth factor receptor (EGFR) mutation status co...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Eun-A, Lee, Haeyoung, Bae, Eunmi, Lim, Jaeok, Shin, Young Kee, Choi, Sang-Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970739/
https://www.ncbi.nlm.nih.gov/pubmed/27483001
http://dx.doi.org/10.1371/journal.pone.0160155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970739/
https://www.ncbi.nlm.nih.gov/pubmed/27483001
http://dx.doi.org/10.1371/journal.pone.0160155

Ejemplares similares